Vitamin D Treatment in Patients With Chronic Hepatitis C

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2008 by Hillel Yaffe Medical Center.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Hillel Yaffe Medical Center
ClinicalTrials.gov Identifier:
NCT00804752
First received: December 7, 2008
Last updated: December 8, 2008
Last verified: December 2008
  Purpose

We hypothesize that patients with Ch.HCV have a low level of vitamin D, and that by raising their vitamin D levels by adding it to their standard treament of Pegylated Interferon and Ribavirin, there will be an increase in their sustained virological response.


Condition Intervention
Chronic Hepatitis C
Drug: Adding vitamin D
Drug: Vitamin D

Study Type: Interventional

Resource links provided by NLM:


Further study details as provided by Hillel Yaffe Medical Center:

Primary Outcome Measures:
  • To increase the sustained virological response [ Time Frame: One year ] [ Designated as safety issue: No ]

Arms Assigned Interventions
Experimental: Vitamin D
An addition of Vitamin D to the standard treatment
Drug: Adding vitamin D
Adding 1000IU/Vitamin D daily
Drug: Vitamin D
Addition of 1000IU/day Vitamin D

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Chronic Hepatitis C Genotype 1

Exclusion Criteria:

  • Vitamin D intoxication Renal Failure Liver Failure Malignancy
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00804752

Locations
Israel
Hillel Yaffe Medical Center Recruiting
Hadera, Israel, 38100
Contact: Saif Abu-Mouch, MD       saif@hy.health.gov.il   
Principal Investigator: Saif Abu-Mouch, MD         
Sub-Investigator: Jacob Yarchovski, MD         
Sub-Investigator: Carlos Singer, MD         
Sub-Investigator: Abed El-Rauf Zeina, MD         
Sponsors and Collaborators
Hillel Yaffe Medical Center
  More Information

No publications provided

Responsible Party: Dr. Saif Abu-Mouch, Hepatology Clinic, Hillel Yaffe Medical Center
ClinicalTrials.gov Identifier: NCT00804752     History of Changes
Other Study ID Numbers: 0040-08-HYMC
Study First Received: December 7, 2008
Last Updated: December 8, 2008
Health Authority: Israel: Ministry of Health

Keywords provided by Hillel Yaffe Medical Center:
Patients with Chronic Hepatitis C

Additional relevant MeSH terms:
Hepatitis
Hepatitis A
Hepatitis, Chronic
Hepatitis C
Hepatitis C, Chronic
Liver Diseases
Digestive System Diseases
Hepatitis, Viral, Human
Virus Diseases
Enterovirus Infections
Picornaviridae Infections
RNA Virus Infections
Flaviviridae Infections
Vitamin D
Ergocalciferols
Vitamins
Bone Density Conservation Agents
Physiological Effects of Drugs
Pharmacologic Actions
Micronutrients
Growth Substances

ClinicalTrials.gov processed this record on April 16, 2014